v3.20.4
OPERATING SEGMENTS - Reconciliation (Details)
kr in Millions, $ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2019
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
item
Dec. 31, 2020
SEK (kr)
item
Dec. 31, 2019
USD ($)
item
Dec. 31, 2019
SEK (kr)
item
Dec. 31, 2018
USD ($)
item
Dec. 31, 2018
SEK (kr)
item
Reconciliation of net income to EBITDA                      
Net earnings (loss)           $ (4,589.4)   $ (149.1)   $ 110.1  
Income tax provision (benefit)           59.9   (22.5)   13.6  
Interest expense           356.9   340.8   342.3  
Depreciation and amortization           498.3   450.0   537.8  
Impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill   $ 466.1 $ 195.9 $ 0.0 $ 1,851.9 2,513.9   84.3   13.8  
Certain operating expense (income)           (9.4)   14.8   24.0  
Equity in (earnings) loss of non-consolidated entities           30.9   (30.6)   (86.7)  
Impairment of equity method investments recorded in equity in earnings (loss) of non-consolidated entities           8.6          
Cash distributions from non-consolidated entities           17.4   35.8   35.2  
Attributable EBITDA           0.2   5.0   7.3  
Investment expense (income)           10.1   (16.0)   (6.2)  
Other expense (income)           66.9   13.3   (108.2)  
Other non-cash rent           (4.9)   25.7      
General and administrative - unallocated:                      
Merger, acquisition and other costs           24.6   15.5   31.3  
Share-based Compensation Cash Portion           25.4   4.4   14.9  
Adjusted EBITDA           (999.2)   771.4   929.2  
Goodwill, Impairment Loss $ 0.0 405.3 156.8   $ 1,744.3 2,306.4          
Impairment of long-lived assets           177.9   84.3   13.8  
Impairment of indefinite-lived intangible assets           15.2   0.0   0.0  
Impairment of definite-lived intangible assets           14.4          
Gain on derivative liability               5.8   66.4  
Loss on repayment of indebtedness           93.6   (16.6)      
Derivative liability fair value adjustment for embedded conversion feature in the Convertible Notes           89.4 kr (89.4) (23.5) kr 23.5 (66.4) kr 66.4
Estimated Credit Losses Contingent Lease Guarantees           (15.0)          
Derivative asset fair value adjustment for contingent call option related to the Class B common stock purchase and cancellation agreement           19.6 kr (19.6) 17.7 kr (17.7) (45.0) kr 45.0
Attributable EBITDA                      
Reconciliation of net income to EBITDA                      
Income tax provision (benefit)           0.1   0.4   0.4  
Interest expense           0.1          
Depreciation and amortization           3.2   3.4   2.6  
Equity in (earnings) loss of non-consolidated entities           (30.9)   30.6   86.7  
Equity in (earnings) loss of non-consolidating entities excluding International theatre joint ventures           27.4   (29.2)   (81.9)  
Equity in earnings (loss) of International theatre joint ventures           (3.5)   1.4   4.8  
Attributable EBITDA           0.2   5.0   7.3  
Investment expense (income)           (0.4)   (0.7)   (0.5)  
Other expense (income)           0.7   0.5      
Other expense                      
General and administrative - unallocated:                      
Loss on repayment of indebtedness   93.6                  
Increases in other expenses related to financing fees   3.0 $ 36.3     39.3          
Other expense | Embedded Derivative Financial Instruments [Member]                      
General and administrative - unallocated:                      
Derivative liability fair value adjustment for embedded conversion feature in the Convertible Notes           109.0       111.4  
Other expense | Call Option [Member]                      
General and administrative - unallocated:                      
Estimated Credit Losses Contingent Lease Guarantees           15.0          
NCM                      
Reconciliation of net income to EBITDA                      
Equity in (earnings) loss of non-consolidated entities           (28.9)          
Impairment of equity method investments recorded in equity in earnings (loss) of non-consolidated entities           16.0          
General and administrative - unallocated:                      
Loss on disposition           1.1          
Screenvision                      
Reconciliation of net income to EBITDA                      
Equity in (earnings) loss of non-consolidated entities                   (30.1)  
DCIP                      
Reconciliation of net income to EBITDA                      
Equity in (earnings) loss of non-consolidated entities           (14.5)   $ (25.4)   (29.1)  
Impairment of equity method investments recorded in equity in earnings (loss) of non-consolidated entities   $ 125.2       8.6          
Oden trade name                      
General and administrative - unallocated:                      
Impairment of indefinite-lived intangible assets           12.5          
Nordic trade names                      
General and administrative - unallocated:                      
Impairment of indefinite-lived intangible assets           2.7          
Domestic theatres                      
General and administrative - unallocated:                      
Goodwill, Impairment Loss           1,276.1          
Impairment of definite-lived intangible assets           14.4          
International theatres                      
General and administrative - unallocated:                      
Goodwill, Impairment Loss           1,030.3          
Tangible asset impairment, number of screens | item               148 148    
International theatres | Nordic trade names                      
Reconciliation of net income to EBITDA                      
Impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill           2.7          
U. S. markets                      
General and administrative - unallocated:                      
Goodwill, Impairment Loss                   $ 13.8  
Impairment of long-lived assets           $ 152.5   $ 84.3      
Tangible asset impairment, number of theatres | item           101 101 40 40 13 13
Tangible asset impairment, number of screens | item           1,139 1,139 512 512 150 150
International markets                      
General and administrative - unallocated:                      
Impairment of long-lived assets           $ 25.4          
Tangible asset impairment, number of theatres | item           37 37 14 14 15 15
Tangible asset impairment, number of screens | item           340 340     118 118
International markets | Oden trade name                      
General and administrative - unallocated:                      
Impairment of long-lived assets           $ 12.5          
Operating Segments [Member] | U. S. markets                      
General and administrative - unallocated:                      
Adjusted EBITDA           (768.2)   $ 575.6   $ 700.5  
Operating Segments [Member] | International markets                      
General and administrative - unallocated:                      
Adjusted EBITDA           $ (231.0)   $ 195.8   $ 228.7